[Monitoring of antitubercular treatments. Value of the determination of serum gamma-glutamyl transpeptidase (gamma-GT)].
D000995:Antitubercular Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis*; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use; D008099:Liver / Q000187:drug effects*; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D005723:gamma-Glutamyltransferase / Q000097:blood*
D000995:Antitubercular Agents; D004977:Ethambutol; D005723:gamma-Glutamyltransferase; D007538:Isoniazid; D012293:Rifampin
La surveillance des traitements antituberculeux. Intérêt du dosage de la gamma-glutamyl-transpeptidase sérique (gammaGT)